0 Comentários
0 Compartilhamentos
386 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Faça o login para curtir, compartilhar e comentar!
-
Antisense Oligonucleotide for Cardiometabolic Disorders Market Advances with Expanding Precision Medicine Research and Innovative RNA-Based Therapeutic DevelopmentAccording to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Cardiometabolic Disorders Market The global antisense oligonucleotide for cardiometabolic disorders market size was valued at USD 310.32 million in 2024 and is expected to reach USD 1,135.19 million by 2032, at a CAGR of 17.60% during the forecast period With the use of...0 Comentários 0 Compartilhamentos 381 Visualizações 0 Anterior
-
Broad-Spectrum Antiviral Therapeutics Market Advances with Rising Preparedness for Emerging Viral Outbreaks and Next-Generation Antiviral Drug DevelopmentAccording to the latest report published by Data Bridge Market Research, the Broad-Spectrum Antiviral Therapeutics Market The global broad-spectrum antiviral therapeutics market size was valued at USD 5.84 billion in 2025 and is expected to reach USD 16.08 billion by 2033, at a CAGR of 13.50% during the forecast period Salient attributes used while forming an influential...0 Comentários 0 Compartilhamentos 370 Visualizações 0 Anterior
-
DiGeorge Syndrome Drug Market Advances with Progress in Rare Disease Research and Development of Targeted Therapeutic ApproachesAccording to the latest report published by Data Bridge Market Research, the DiGeorge Syndrome Drug Market The global DiGeorge Syndrome Drug Market was valued at USD 365.4 million in 2024 and is expected to reach USD 608.7 million by 2032.During the forecast period of 2025 to 2032, the market is projected to grow at a CAGR of 6.5% DiGeorge Syndrome Drug Market is the finest...0 Comentários 0 Compartilhamentos 405 Visualizações 0 Anterior
-
Farber’s Disease Drug Market Expands with Advancements in Rare Disease Therapeutics and Ongoing Innovation in Precision MedicineAccording to the latest report published by Data Bridge Market Research, the Farber’s Disease Drug Market The Global Farber’s Disease Drug Market size was valued at USD 2.1 billion in 2024 and is expected to reach USD 3.3 billion by 2032, at a CAGR of 6.2% during the forecast period Farber’s Disease Drug Market analysis report has studied key opportunities in...0 Comentários 0 Compartilhamentos 374 Visualizações 0 Anterior
-
Histone Deacetylase Inhibitors Market Advances with Expanding Epigenetic Research and Development of Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market report is generated by considering the...0 Comentários 0 Compartilhamentos 358 Visualizações 0 Anterior
-
Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...0 Comentários 0 Compartilhamentos 479 Visualizações 0 Anterior
-
Long-Acting Recombinant Hormone Biosimilars Market Expands with Rising Demand for Cost-Effective Biologics and Advanced Endocrine TherapiesAccording to the latest report published by Data Bridge Market Research, the Long-Acting Recombinant Hormone Biosimilars Market The global long-acting recombinant hormone biosimilars market size was valued at USD 198.00 million in 2025 and is expected to reach USD 421.35 million by 2033, at a CAGR of 9.90% during the forecast period The large scale Long-Acting Recombinant Hormone...0 Comentários 0 Compartilhamentos 386 Visualizações 0 Anterior
English
Romaian
Greek